Leukocytosis: Difference between revisions
Ostermayer (talk | contribs) No edit summary |
(Formatting: removed bold) |
||
| Line 1: | Line 1: | ||
==Background== | ==Background== | ||
*Leukocytosis is defined as a WBC count > 11,000 cells/μL in adults<ref name="riley">Riley LK, Rupert J. Evaluation of patients with leukocytosis. ''Am Fam Physician''. 2015;92(11):1004-1011. PMID 26760415.</ref> | *Leukocytosis is defined as a WBC count > 11,000 cells/μL in adults<ref name="riley">Riley LK, Rupert J. Evaluation of patients with leukocytosis. ''Am Fam Physician''. 2015;92(11):1004-1011. PMID 26760415.</ref> | ||
* | *Hyperleukocytosis is defined as WBC > 100,000 cells/μL and is a hematologic emergency<ref name="statpearls">Chabot-Richards DS, George TI. Leukocytosis. In: ''StatPearls''. Treasure Island (FL): StatPearls Publishing; 2024. PMID 32809717.</ref> | ||
* | *Leukemoid reaction refers to WBC 50,000–100,000 cells/μL from a reactive (non-malignant) cause<ref name="riley"/> | ||
*The WBC count can double within hours from stress demargination (surgery, trauma, exercise, seizures, emotional stress)<ref name="riley"/> | *The WBC count can double within hours from stress demargination (surgery, trauma, exercise, seizures, emotional stress)<ref name="riley"/> | ||
*Classification is based on which cell line is predominantly elevated: | *Classification is based on which cell line is predominantly elevated: | ||
** | **Neutrophilia (> 7,700/μL) — most common; typically infection, inflammation, or stress | ||
** | **Lymphocytosis (> 4,800/μL) — viral infections, CLL | ||
** | **Monocytosis (> 800/μL) — chronic infections, autoimmune disease, malignancy | ||
** | **Eosinophilia (> 500/μL) — allergic, parasitic, drug reactions, malignancy | ||
** | **Basophilia (> 100/μL) — myeloproliferative neoplasms (especially CML) | ||
*Always interpret the '''absolute''' cell count (total WBC × differential percentage), not the relative percentage alone<ref name="riley"/> | *Always interpret the '''absolute''' cell count (total WBC × differential percentage), not the relative percentage alone<ref name="riley"/> | ||
*Age-specific considerations: | *Age-specific considerations: | ||
** | **Neonates: normal WBC up to 30,000/μL at birth; shifts toward lymphocyte predominance in early childhood | ||
** | **Pregnancy: normal WBC up to ~13,000–15,000/μL in third trimester; leukocytosis is unreliable for diagnosing infection in the postpartum period<ref name="riley"/> | ||
==Clinical Features== | ==Clinical Features== | ||
| Line 24: | Line 24: | ||
**Trauma, burns, post-surgical state | **Trauma, burns, post-surgical state | ||
**Medication changes (corticosteroids, lithium, epinephrine, beta-agonists) | **Medication changes (corticosteroids, lithium, epinephrine, beta-agonists) | ||
* | *Red flags for malignant etiology: | ||
**Unexplained constitutional symptoms (B symptoms: fever, night sweats, weight loss > 10%) | **Unexplained constitutional symptoms (B symptoms: fever, night sweats, weight loss > 10%) | ||
**Hepatosplenomegaly or diffuse lymphadenopathy | **Hepatosplenomegaly or diffuse lymphadenopathy | ||
| Line 30: | Line 30: | ||
**WBC > 50,000/μL without clear reactive cause | **WBC > 50,000/μL without clear reactive cause | ||
**Blasts on peripheral smear | **Blasts on peripheral smear | ||
* | *Red flags for leukostasis (WBC > 100,000):<ref name="alcantara">Alcantara R, Klemisch R. Hyperleukocytosis and leukostasis. ''ACEP Critical Care Medicine Section''. January 2025.</ref> | ||
**Dyspnea, hypoxia (pulmonary leukostasis — worst prognostic sign) | **Dyspnea, hypoxia (pulmonary leukostasis — worst prognostic sign) | ||
**Altered mental status, headache, visual changes, focal deficits (CNS leukostasis) | **Altered mental status, headache, visual changes, focal deficits (CNS leukostasis) | ||
| Line 42: | Line 42: | ||
====Neutrophilia (Most Common)==== | ====Neutrophilia (Most Common)==== | ||
* | *Infection: Bacterial (most common overall), fungal | ||
* | *Inflammation: Pancreatitis, inflammatory bowel disease, vasculitis, gout, rheumatologic disorders | ||
* | *Stress/physiologic: Surgery, trauma, exercise, seizures, pain, emotional stress, labor | ||
* | *Medications: Corticosteroids (causes demargination; WBC can rise 2,000–5,000/μL within hours), lithium, epinephrine, beta-agonists, G-CSF/GM-CSF | ||
* | *Tissue necrosis: MI, burns, crush injury, ischemic bowel | ||
* | *Smoking (chronic mild neutrophilia)<ref name="riley"/> | ||
* | *Asplenia/post-splenectomy | ||
* | *Malignancy: CML, other myeloproliferative neoplasms, solid tumors (paraneoplastic) | ||
* | *Leukemoid reaction: Severe infection (''C. difficile'', tuberculosis), hemorrhage, ethylene glycol poisoning | ||
====Lymphocytosis==== | ====Lymphocytosis==== | ||
* | *Viral infections: EBV (mononucleosis), CMV, hepatitis, HIV (acute), pertussis, influenza | ||
* | *Malignancy: [[Chronic Lymphocytic Leukemia|CLL]] (most common cause in adults > 50), ALL, lymphoma | ||
* | *Other: Hyperthyroidism, adrenal insufficiency, autoimmune disease, post-splenectomy | ||
*Reactive lymphocytosis can reach 20,000–30,000/μL; atypical lymphocytes on smear suggest viral etiology<ref name="statpearls"/> | *Reactive lymphocytosis can reach 20,000–30,000/μL; atypical lymphocytes on smear suggest viral etiology<ref name="statpearls"/> | ||
| Line 78: | Line 78: | ||
==Evaluation== | ==Evaluation== | ||
===Initial Workup=== | ===Initial Workup=== | ||
* | *[[CBC]] with differential — determine which cell line is elevated; calculate absolute counts | ||
* | *[[Peripheral smear]] — '''essential''' if:<ref name="riley"/> | ||
**WBC > 25,000–30,000/μL without clear reactive cause | **WBC > 25,000–30,000/μL without clear reactive cause | ||
**Concern for malignancy (blasts, left shift, atypical cells) | **Concern for malignancy (blasts, left shift, atypical cells) | ||
**Concurrent cytopenias (anemia, thrombocytopenia) | **Concurrent cytopenias (anemia, thrombocytopenia) | ||
**Evaluate for blasts (leukemia), atypical lymphocytes (viral), left shift (severe infection), leukoerythroblastic picture (marrow infiltration) | **Evaluate for blasts (leukemia), atypical lymphocytes (viral), left shift (severe infection), leukoerythroblastic picture (marrow infiltration) | ||
* | *BMP/CMP — electrolytes (pseudohyperkalemia can occur with extreme leukocytosis due to lysis in the tube), renal function, glucose, LDH, uric acid | ||
* | *Blood cultures — if febrile, hemodynamically unstable, or concern for bacteremia/sepsis | ||
* | *Urinalysis — if urinary source suspected | ||
* | *CXR — if respiratory symptoms or concern for pneumonia | ||
* | *Lactate — if concern for sepsis or tissue hypoperfusion | ||
===Directed Workup Based on Clinical Scenario=== | ===Directed Workup Based on Clinical Scenario=== | ||
* | *Suspected infection: Appropriate cultures, imaging, inflammatory markers (CRP, procalcitonin) | ||
* | *Suspected malignancy (blasts on smear, unexplained extreme leukocytosis): | ||
**'''Emergent hematology consultation''' | **'''Emergent hematology consultation''' | ||
** | **Flow cytometry (for immunophenotyping) | ||
**LDH, uric acid, phosphorus, calcium, potassium (tumor lysis panel) | **LDH, uric acid, phosphorus, calcium, potassium (tumor lysis panel) | ||
**Coagulation studies (DIC screen — up to 40% of patients with hyperleukocytosis develop DIC)<ref name="alcantara"/> | **Coagulation studies (DIC screen — up to 40% of patients with hyperleukocytosis develop DIC)<ref name="alcantara"/> | ||
* | *Hyperleukocytosis (WBC > 100,000): | ||
**All of the above PLUS continuous monitoring, ICU admission | **All of the above PLUS continuous monitoring, ICU admission | ||
**Avoid unnecessary RBC transfusion (increases blood viscosity and may worsen leukostasis symptoms) | **Avoid unnecessary RBC transfusion (increases blood viscosity and may worsen leukostasis symptoms) | ||
* | *Drug-induced: Review medication list — corticosteroids are the most common cause of drug-induced leukocytosis in the ED; onset within hours of administration | ||
===Common ED Pitfall=== | ===Common ED Pitfall=== | ||
* | *Steroid-induced leukocytosis: A single dose of dexamethasone (e.g. for croup, asthma, pharyngitis) can elevate WBC by 2,000–5,000/μL within 4–8 hours via neutrophil demargination; this does NOT indicate infection and should not prompt unnecessary antibiotic therapy<ref name="riley"/> | ||
==Management== | ==Management== | ||
* | *Directed at the underlying cause — leukocytosis itself rarely requires specific treatment<ref name="statpearls"/> | ||
* | *Infection: Appropriate antibiotics/antivirals/antifungals based on suspected source | ||
* | *Drug-induced: Discontinue or adjust offending agent if clinically appropriate | ||
*'''Leukostasis / hyperleukocytosis (oncologic emergency):'''<ref name="alcantara"/> | *'''Leukostasis / hyperleukocytosis (oncologic emergency):'''<ref name="alcantara"/> | ||
**'''Emergent hematology/oncology consultation''' | **'''Emergent hematology/oncology consultation''' | ||
** | **Aggressive IV hydration (target UOP > 2 mL/kg/hr) to prevent/treat tumor lysis syndrome | ||
** | **Tumor lysis prophylaxis: Allopurinol or rasburicase (do NOT alkalinize urine if using rasburicase) | ||
** | **Hydroxyurea (50–100 mg/kg/day) — cytoreductive therapy that can be initiated prior to identifying leukemia subtype | ||
** | **Leukapheresis — controversial; may be considered as temporizing measure in symptomatic leukostasis; avoid in APL (acute promyelocytic leukemia)<ref name="alcantara"/> | ||
** | **Avoid RBC transfusion unless critical anemia — increases viscosity and can precipitate/worsen leukostasis | ||
**Monitor electrolytes, coagulation studies, and CBC every 4–6 hours | **Monitor electrolytes, coagulation studies, and CBC every 4–6 hours | ||
** | **DIC management if present (see [[Disseminated Intravascular Coagulation]]) | ||
* | *Suspected acute leukemia (blasts on smear): | ||
**Emergent hematology consultation even if WBC is not extremely elevated | **Emergent hematology consultation even if WBC is not extremely elevated | ||
**Tumor lysis panel and prophylaxis | **Tumor lysis panel and prophylaxis | ||
| Line 124: | Line 124: | ||
==Disposition== | ==Disposition== | ||
* | *Admit / ICU: | ||
**Hyperleukocytosis (WBC > 100,000/μL) | **Hyperleukocytosis (WBC > 100,000/μL) | ||
**Symptomatic leukostasis (pulmonary or CNS involvement) — '''one-week mortality ~50% untreated'''<ref name="alcantara"/> | **Symptomatic leukostasis (pulmonary or CNS involvement) — '''one-week mortality ~50% untreated'''<ref name="alcantara"/> | ||
| Line 130: | Line 130: | ||
**Leukocytosis with sepsis, hemodynamic instability, or organ dysfunction | **Leukocytosis with sepsis, hemodynamic instability, or organ dysfunction | ||
**DIC or tumor lysis syndrome | **DIC or tumor lysis syndrome | ||
* | *Admit (general floor): | ||
**Significant leukocytosis (> 25,000–30,000/μL) with unidentified source requiring inpatient workup | **Significant leukocytosis (> 25,000–30,000/μL) with unidentified source requiring inpatient workup | ||
**Infection requiring IV antibiotics | **Infection requiring IV antibiotics | ||
**New unexplained cytopenias alongside leukocytosis (pancytopenia with elevated WBC may indicate marrow pathology) | **New unexplained cytopenias alongside leukocytosis (pancytopenia with elevated WBC may indicate marrow pathology) | ||
* | *Discharge with follow-up: | ||
**Mild leukocytosis (11,000–20,000/μL) with identified and treated cause (e.g. UTI, cellulitis, steroid-induced) | **Mild leukocytosis (11,000–20,000/μL) with identified and treated cause (e.g. UTI, cellulitis, steroid-induced) | ||
**Asymptomatic, well-appearing patient with known chronic mild leukocytosis (e.g. smoking, obesity, chronic steroid use) | **Asymptomatic, well-appearing patient with known chronic mild leukocytosis (e.g. smoking, obesity, chronic steroid use) | ||
**Ensure repeat CBC with differential within 1–2 weeks if new finding and no clearly identified cause | **Ensure repeat CBC with differential within 1–2 weeks if new finding and no clearly identified cause | ||
** | **Refer to hematology if: persistent unexplained leukocytosis, WBC > 30,000/μL without reactive cause, concurrent cytopenias, abnormal peripheral smear, or concern for malignancy<ref name="riley"/> | ||
* | *Poison control: Consider consultation if drug-induced or toxicologic cause suspected (1-800-222-1222) | ||
==See Also== | ==See Also== | ||
Latest revision as of 16:15, 19 March 2026
Background
- Leukocytosis is defined as a WBC count > 11,000 cells/μL in adults[1]
- Hyperleukocytosis is defined as WBC > 100,000 cells/μL and is a hematologic emergency[2]
- Leukemoid reaction refers to WBC 50,000–100,000 cells/μL from a reactive (non-malignant) cause[1]
- The WBC count can double within hours from stress demargination (surgery, trauma, exercise, seizures, emotional stress)[1]
- Classification is based on which cell line is predominantly elevated:
- Neutrophilia (> 7,700/μL) — most common; typically infection, inflammation, or stress
- Lymphocytosis (> 4,800/μL) — viral infections, CLL
- Monocytosis (> 800/μL) — chronic infections, autoimmune disease, malignancy
- Eosinophilia (> 500/μL) — allergic, parasitic, drug reactions, malignancy
- Basophilia (> 100/μL) — myeloproliferative neoplasms (especially CML)
- Always interpret the absolute cell count (total WBC × differential percentage), not the relative percentage alone[1]
- Age-specific considerations:
- Neonates: normal WBC up to 30,000/μL at birth; shifts toward lymphocyte predominance in early childhood
- Pregnancy: normal WBC up to ~13,000–15,000/μL in third trimester; leukocytosis is unreliable for diagnosing infection in the postpartum period[1]
Clinical Features
- Leukocytosis itself is a laboratory finding, not a disease — clinical features depend on the underlying cause
- May be an incidental finding or occur in the context of:
- Fever, chills, localizing signs of infection
- Malaise, fatigue, weight loss, night sweats, bruising (concerning for malignancy)
- Abdominal pain (appendicitis, cholecystitis, diverticulitis, abscess)
- Chest pain, dyspnea, cough (pneumonia, PE, ACS)
- Trauma, burns, post-surgical state
- Medication changes (corticosteroids, lithium, epinephrine, beta-agonists)
- Red flags for malignant etiology:
- Unexplained constitutional symptoms (B symptoms: fever, night sweats, weight loss > 10%)
- Hepatosplenomegaly or diffuse lymphadenopathy
- Petechiae, ecchymoses, or mucosal bleeding (concurrent thrombocytopenia)
- WBC > 50,000/μL without clear reactive cause
- Blasts on peripheral smear
- Red flags for leukostasis (WBC > 100,000):[3]
- Dyspnea, hypoxia (pulmonary leukostasis — worst prognostic sign)
- Altered mental status, headache, visual changes, focal deficits (CNS leukostasis)
- Priapism
- Signs of tumor lysis syndrome or DIC
Differential Diagnosis
Leukocytosis
- Normally responding bone marrow
- Infection
- Inflammation: tissue necrosis, infarction, burns, arthritis
- Stress: overexertion, seizures, anxiety, anesthesia
- Drugs: corticosteroids, lithium, beta agonists
- Trauma: splenectomy
- Hemolytic anemia
- Leukemoid malignancy
- Abnormal bone marrow
By Cell Type
Neutrophilia (Most Common)
- Infection: Bacterial (most common overall), fungal
- Inflammation: Pancreatitis, inflammatory bowel disease, vasculitis, gout, rheumatologic disorders
- Stress/physiologic: Surgery, trauma, exercise, seizures, pain, emotional stress, labor
- Medications: Corticosteroids (causes demargination; WBC can rise 2,000–5,000/μL within hours), lithium, epinephrine, beta-agonists, G-CSF/GM-CSF
- Tissue necrosis: MI, burns, crush injury, ischemic bowel
- Smoking (chronic mild neutrophilia)[1]
- Asplenia/post-splenectomy
- Malignancy: CML, other myeloproliferative neoplasms, solid tumors (paraneoplastic)
- Leukemoid reaction: Severe infection (C. difficile, tuberculosis), hemorrhage, ethylene glycol poisoning
Lymphocytosis
- Viral infections: EBV (mononucleosis), CMV, hepatitis, HIV (acute), pertussis, influenza
- Malignancy: CLL (most common cause in adults > 50), ALL, lymphoma
- Other: Hyperthyroidism, adrenal insufficiency, autoimmune disease, post-splenectomy
- Reactive lymphocytosis can reach 20,000–30,000/μL; atypical lymphocytes on smear suggest viral etiology[2]
Monocytosis
- Chronic infections (tuberculosis, endocarditis, brucellosis)
- Autoimmune/inflammatory disease (SLE, sarcoidosis, IBD)
- Malignancy (CMML, Hodgkin lymphoma)
- Recovery phase of acute infection or neutropenia
Eosinophilia
- See main article: Eosinophilia
- Allergic disease (asthma, atopic dermatitis, allergic rhinitis)
- Parasitic infections (especially tissue-invasive helminths)
- Drug reactions (DRESS syndrome, other drug hypersensitivity)
- Malignancy (Hodgkin lymphoma, hypereosinophilic syndrome)
- Adrenal insufficiency
Basophilia
- Myeloproliferative neoplasms (CML — basophilia is an important clue)
- Allergic/inflammatory conditions (rarely elevates basophils above threshold alone)
Evaluation
Initial Workup
- CBC with differential — determine which cell line is elevated; calculate absolute counts
- Peripheral smear — essential if:[1]
- WBC > 25,000–30,000/μL without clear reactive cause
- Concern for malignancy (blasts, left shift, atypical cells)
- Concurrent cytopenias (anemia, thrombocytopenia)
- Evaluate for blasts (leukemia), atypical lymphocytes (viral), left shift (severe infection), leukoerythroblastic picture (marrow infiltration)
- BMP/CMP — electrolytes (pseudohyperkalemia can occur with extreme leukocytosis due to lysis in the tube), renal function, glucose, LDH, uric acid
- Blood cultures — if febrile, hemodynamically unstable, or concern for bacteremia/sepsis
- Urinalysis — if urinary source suspected
- CXR — if respiratory symptoms or concern for pneumonia
- Lactate — if concern for sepsis or tissue hypoperfusion
Directed Workup Based on Clinical Scenario
- Suspected infection: Appropriate cultures, imaging, inflammatory markers (CRP, procalcitonin)
- Suspected malignancy (blasts on smear, unexplained extreme leukocytosis):
- Emergent hematology consultation
- Flow cytometry (for immunophenotyping)
- LDH, uric acid, phosphorus, calcium, potassium (tumor lysis panel)
- Coagulation studies (DIC screen — up to 40% of patients with hyperleukocytosis develop DIC)[3]
- Hyperleukocytosis (WBC > 100,000):
- All of the above PLUS continuous monitoring, ICU admission
- Avoid unnecessary RBC transfusion (increases blood viscosity and may worsen leukostasis symptoms)
- Drug-induced: Review medication list — corticosteroids are the most common cause of drug-induced leukocytosis in the ED; onset within hours of administration
Common ED Pitfall
- Steroid-induced leukocytosis: A single dose of dexamethasone (e.g. for croup, asthma, pharyngitis) can elevate WBC by 2,000–5,000/μL within 4–8 hours via neutrophil demargination; this does NOT indicate infection and should not prompt unnecessary antibiotic therapy[1]
Management
- Directed at the underlying cause — leukocytosis itself rarely requires specific treatment[2]
- Infection: Appropriate antibiotics/antivirals/antifungals based on suspected source
- Drug-induced: Discontinue or adjust offending agent if clinically appropriate
- Leukostasis / hyperleukocytosis (oncologic emergency):[3]
- Emergent hematology/oncology consultation
- Aggressive IV hydration (target UOP > 2 mL/kg/hr) to prevent/treat tumor lysis syndrome
- Tumor lysis prophylaxis: Allopurinol or rasburicase (do NOT alkalinize urine if using rasburicase)
- Hydroxyurea (50–100 mg/kg/day) — cytoreductive therapy that can be initiated prior to identifying leukemia subtype
- Leukapheresis — controversial; may be considered as temporizing measure in symptomatic leukostasis; avoid in APL (acute promyelocytic leukemia)[3]
- Avoid RBC transfusion unless critical anemia — increases viscosity and can precipitate/worsen leukostasis
- Monitor electrolytes, coagulation studies, and CBC every 4–6 hours
- DIC management if present (see Disseminated Intravascular Coagulation)
- Suspected acute leukemia (blasts on smear):
- Emergent hematology consultation even if WBC is not extremely elevated
- Tumor lysis panel and prophylaxis
- Evaluate for Tumor Lysis Syndrome, DIC, and Febrile Neutropenia (if neutropenic despite high total WBC — this can occur when blasts predominate but functional neutrophils are low)
Disposition
- Admit / ICU:
- Hyperleukocytosis (WBC > 100,000/μL)
- Symptomatic leukostasis (pulmonary or CNS involvement) — one-week mortality ~50% untreated[3]
- New blasts on peripheral smear (suspected acute leukemia)
- Leukocytosis with sepsis, hemodynamic instability, or organ dysfunction
- DIC or tumor lysis syndrome
- Admit (general floor):
- Significant leukocytosis (> 25,000–30,000/μL) with unidentified source requiring inpatient workup
- Infection requiring IV antibiotics
- New unexplained cytopenias alongside leukocytosis (pancytopenia with elevated WBC may indicate marrow pathology)
- Discharge with follow-up:
- Mild leukocytosis (11,000–20,000/μL) with identified and treated cause (e.g. UTI, cellulitis, steroid-induced)
- Asymptomatic, well-appearing patient with known chronic mild leukocytosis (e.g. smoking, obesity, chronic steroid use)
- Ensure repeat CBC with differential within 1–2 weeks if new finding and no clearly identified cause
- Refer to hematology if: persistent unexplained leukocytosis, WBC > 30,000/μL without reactive cause, concurrent cytopenias, abnormal peripheral smear, or concern for malignancy[1]
- Poison control: Consider consultation if drug-induced or toxicologic cause suspected (1-800-222-1222)
See Also
- Eosinophilia
- Leukemia
- Febrile Neutropenia
- Tumor Lysis Syndrome
- Disseminated Intravascular Coagulation
- CBC
- Peripheral blood smear
- Sepsis
- Leukopenia
- Pancytopenia
- Lymphadenopathy
External Links
- Leukocytosis - StatPearls
- Evaluation of Patients with Leukocytosis - Am Fam Physician 2015
- Hyperleukocytosis and Leukostasis - ACEP Critical Care Section 2025
References
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8 Riley LK, Rupert J. Evaluation of patients with leukocytosis. Am Fam Physician. 2015;92(11):1004-1011. PMID 26760415.
- ↑ 2.0 2.1 2.2 Chabot-Richards DS, George TI. Leukocytosis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024. PMID 32809717.
- ↑ 3.0 3.1 3.2 3.3 3.4 Alcantara R, Klemisch R. Hyperleukocytosis and leukostasis. ACEP Critical Care Medicine Section. January 2025.
